Publication | Closed Access

Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties

NeuropsychologyPsychoactive DrugPsychiatryNeurophysiologyMedicinePsychotropic MedicationMesolimbic Dopamine SystemsPsychopharmacologyNeuropharmacologyWeak Cataleptogenic PropertiesNeuroscienceBiological PsychiatryDopaminePharmacologySocial Sciences